Department of Gastroenterology, Asian Institute of Gastroenterology Hospitals, Hyderabad, India.
Department of Pathology, Asian Institute of Gastroenterology Hospitals, Hyderabad, India.
Gastrointest Endosc. 2021 Mar;93(3):616-626. doi: 10.1016/j.gie.2020.07.001. Epub 2020 Jul 12.
Novel motorized spiral enteroscopy (NMSE) is a recent advancement in the field of enteroscopy and offers multiple features, including self-propulsion, better irrigation, and shorter enteroscope length with a larger channel. The aim of this study was to evaluate the efficacy in terms of diagnostic yield and therapeutic success of NMSE in patients undergoing enteroscopy by antegrade and/or retrograde approaches for suspected small-bowel disease.
We retrospectively evaluated consecutive patients with symptomatic small-bowel disease who underwent enteroscopy over a 6-month period. Diagnostic yield, therapeutic success, total enteroscopy rate (TER), technical success, total procedural time, depth of maximal insertion, and adverse events related to the NMSE procedure were noted.
Of 61 patients (mean age, 45.67 ± 15.37 years; 43 men) included for NMSE, 57 patients underwent successful enteroscopy with a technical success of 93.4%. The overall diagnostic yield was 65.5% (95% confidence interval, 52.31-77.27) and 70.1% (95% confidence interval, 56.60-81.57) in patients who underwent successful NMSE; TER was 60.6%: 31.1% by the antegrade approach and 29.5% by a combined antegrade and retrograde approach. Depth of maximal insertion and procedural time was of 465 cm (range, 100-650) and 40 minutes (range, 25-60), respectively, by the antegrade approach and 140 cm (range, 50-200) and 35 minutes (range, 30-60) by the retrograde route. Lesions were classified as inflammatory (n = 25), vascular (n = 10), and mass (n = 4). Biopsy specimens were obtained in 50.8% subjects, and 23% patients underwent therapeutic procedures. No major adverse events were seen.
NMSE is a promising technology, showing high efficacy as a diagnostic and therapeutic tool in the management of otherwise difficult-to-treat small-bowel disease.
新型电动螺旋内镜(NMSE)是内镜领域的一项新进展,具有自推进、更好的冲洗和更短的内镜长度以及更大的通道等多种特点。本研究旨在评估经逆行和/或顺行入路进行 NMSE 检查疑似小肠疾病患者的诊断效能和治疗成功率。
我们回顾性评估了在 6 个月期间接受内镜检查的有症状小肠疾病连续患者。记录诊断率、治疗成功率、总内镜率(TER)、技术成功率、总手术时间、最大插入深度和与 NMSE 程序相关的不良事件。
在 61 例(平均年龄 45.67 ± 15.37 岁;43 例男性)接受 NMSE 的患者中,57 例成功进行了内镜检查,技术成功率为 93.4%。总的诊断率为 65.5%(95%置信区间,52.31-77.27),成功进行 NMSE 的患者为 70.1%(95%置信区间,56.60-81.57);TER 为 60.6%:顺行途径为 31.1%,顺行和逆行联合途径为 29.5%。最大插入深度和手术时间分别为经顺行途径的 465cm(范围,100-650)和 40 分钟(范围,25-60),经逆行途径的 140cm(范围,50-200)和 35 分钟(范围,30-60)。病变分为炎症性(n=25)、血管性(n=10)和肿块性(n=4)。50.8%的患者获得了活检标本,23%的患者进行了治疗性操作。未观察到主要不良事件。
NMSE 是一种很有前途的技术,作为一种诊断和治疗工具,在治疗其他难以治疗的小肠疾病方面具有很高的疗效。